Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
591 | 3186 | 52.4 | 91% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRPV1 | Author keyword | 318 | 51% | 14% | 450 |
2 | TRPM8 | Author keyword | 197 | 80% | 4% | 123 |
3 | TRPA1 | Author keyword | 197 | 65% | 6% | 186 |
4 | TRPV4 | Author keyword | 115 | 65% | 3% | 111 |
5 | TRPV1 ANTAGONIST | Author keyword | 92 | 92% | 1% | 36 |
6 | ICILIN | Author keyword | 72 | 93% | 1% | 27 |
7 | CAPSAICIN | Author keyword | 49 | 12% | 13% | 403 |
8 | TRP CHANNELS | Author keyword | 49 | 35% | 4% | 116 |
9 | VR1 | Author keyword | 46 | 57% | 2% | 54 |
10 | TRPV2 | Author keyword | 42 | 73% | 1% | 32 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRPV1 | 318 | 51% | 14% | 450 | Search TRPV1 | Search TRPV1 |
2 | TRPM8 | 197 | 80% | 4% | 123 | Search TRPM8 | Search TRPM8 |
3 | TRPA1 | 197 | 65% | 6% | 186 | Search TRPA1 | Search TRPA1 |
4 | TRPV4 | 115 | 65% | 3% | 111 | Search TRPV4 | Search TRPV4 |
5 | TRPV1 ANTAGONIST | 92 | 92% | 1% | 36 | Search TRPV1+ANTAGONIST | Search TRPV1+ANTAGONIST |
6 | ICILIN | 72 | 93% | 1% | 27 | Search ICILIN | Search ICILIN |
7 | CAPSAICIN | 49 | 12% | 13% | 403 | Search CAPSAICIN | Search CAPSAICIN |
8 | TRP CHANNELS | 49 | 35% | 4% | 116 | Search TRP+CHANNELS | Search TRP+CHANNELS |
9 | VR1 | 46 | 57% | 2% | 54 | Search VR1 | Search VR1 |
10 | TRPV2 | 42 | 73% | 1% | 32 | Search TRPV2 | Search TRPV2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CAPSAICIN RECEPTOR | 846 | 54% | 34% | 1075 |
2 | HEAT EVOKED ACTIVATION | 239 | 82% | 4% | 140 |
3 | ION CHANNEL TRPA1 | 237 | 77% | 5% | 160 |
4 | VR1 | 189 | 77% | 4% | 127 |
5 | VANILLOID RECEPTOR TRPV1 | 164 | 67% | 5% | 148 |
6 | VANILLOID RECEPTOR 1 | 160 | 56% | 6% | 195 |
7 | VANILLOID RECEPTOR | 144 | 43% | 8% | 255 |
8 | ACTIVATED ION CHANNEL | 133 | 73% | 3% | 101 |
9 | PAIN PATHWAY | 89 | 51% | 4% | 124 |
10 | TRPV1 | 84 | 40% | 5% | 164 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
TRP Channels and Pain | 2013 | 78 | 145 | 83% |
Functional diversity and evolutionary dynamics of thermoTRP channels | 2015 | 3 | 61 | 82% |
Cellular and Molecular Mechanisms of Pain | 2009 | 612 | 150 | 39% |
Targeting TRP channels for pain relief | 2013 | 43 | 136 | 88% |
Transient receptor potential channels as therapeutic targets | 2011 | 152 | 170 | 59% |
Transient receptor potential vanilloid type 1 antagonists: a patent review (2011-2014) | 2015 | 2 | 32 | 81% |
The functions of TRPA1 and TRPV1: moving away from sensory nerves | 2012 | 75 | 114 | 72% |
Transient receptor potential ( TRP) channels: a clinical perspective | 2014 | 21 | 387 | 56% |
The thermo-TRP ion channel family: properties and therapeutic implications | 2012 | 58 | 174 | 84% |
Transient receptor potential channels: targeting pain at the source | 2009 | 209 | 158 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ION CHANNEL | 38 | 45% | 2.0% | 65 |
2 | TRP PLATFORM LEUVEN TRPLE | 11 | 65% | 0.3% | 11 |
3 | PHYSIOL BIOPHYS SCI | 10 | 46% | 0.5% | 17 |
4 | SECT CELL SIGNALING | 10 | 46% | 0.5% | 16 |
5 | SENSORY GRP | 9 | 67% | 0.3% | 8 |
6 | ORIONPHARMA | 8 | 70% | 0.2% | 7 |
7 | ANIM PHYSIOL BIOPHYS | 7 | 43% | 0.4% | 13 |
8 | LEADING MOL MODELING DRUG DESIGN | 7 | 67% | 0.2% | 6 |
9 | MOL CELLULAR NEUROL | 6 | 71% | 0.2% | 5 |
10 | CORE CELL SIGNALING DRUG DISCOVERY | 5 | 47% | 0.3% | 8 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165473 | RESINIFERATOXIN//NEONATAL CAPSAICIN//H 3RESINIFERATOXIN BINDING |
2 | 0.0000147058 | TRPM7//TRPM4//TRPM2 |
3 | 0.0000080754 | ACID SENSING ION CHANNEL//ACID SENSING ION CHANNELS//ASIC3 |
4 | 0.0000068433 | STIM1//ORAI1//ORAI |
5 | 0.0000067587 | VISCERAL PAIN//COLORECTAL DISTENSION//VISCERAL HYPERALGESIA |
6 | 0.0000066493 | MUCOLIPIDOSIS TYPE IV//MUCOLIPIN//MUCOLIPIDOSIS IV |
7 | 0.0000063257 | NEUROSYST//MOL NEUROBIOL PAIN//BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE |
8 | 0.0000059853 | CAPSAICINOIDS//DIHYDROCAPSAICIN//CAPSINOIDS |
9 | 0.0000057782 | EP1 ANTAGONIST//VISCERAL NOCICEPTOR//POLYMODAL RECEPTOR |
10 | 0.0000047801 | CAPSAICIN SENSITIVE SENSORY NEURONS//BIODEF MED//REPROD ENGN |